Design a site like this with WordPress.com
Get started

Topical Pain Relief Market – Industry Analysis, Market Size, Share, Trends, Application Analysis, Growth And Forecast 2021 – 2026

  Topical Pain Relief Market size is forecast to reach $11.78 billion by 2025, growing at a CAGR of 6.25% during the forecast period 2020-2025. Topical Pain Relief is designed to relieve pain that is sprayed on, rubbed in, or applied as patches onto the skin over painful muscles or joints. An increase in the prevalence of arthritis and other bone-related conditions are the major factors driving the growth of the market. Rising geriatric population and the increase in the adoption of topical pain relief by sports players is set to further enhance the overall market demand for topical pain relief during the forecast period 2020-2025.

Report Coverage

The report: “Topical Pain Relief Market Forecast (2020-2025)”, by IndustryARC, covers an in-depth analysis of the following segments of the Topical Pain Relief Market. 
By Type: Prescription Pain Relief, Over-The-Counter Pain ReliefBy Therapeutic Class: Non-Opioids, Nonsteroidal Anti-Inflammatory Drug, Methyl Salicylate, Capsaicin, Lidocaine, Opioids, Buprenorphine and FentanylBy Formulation: Cream, Gel, Spray, and PatchBy Distribution Channel: Pharmacy Drug Store, E-Commerce, OthersBy Geography: North America, Europe, Asia Pacific and Rest of the World (RoW)

Key Takeaways

  • North America dominated the Topical Pain Relief Market in 2019 owing to the rising geriatric population and increasing incidences of sports injury. The Topical Pain Relief Market scope for different regions will be provided in the final report.
  • Increase in demand for topical pain relief by sports players and rise in adoption of topical pain relief is likely to aid in the market growth of the topical pain relief market.
  • Detailed analysis of the Strength, Weakness, and Opportunities of the prominent players operating in the market will be provided in the Topical Pain Relief Market report.
  • Topical Pain Relief Medications can irritate skin and odor or unpleasant smell of topical pain relief is set to create hurdles for the Topical Pain Relief Market.

Therapeutic Class- Segment Analysis

The non-Opioids segment held the largest share in the Topical Pain Relief in 2019 and is estimated to grow at a CAGR of 5.41% during the forecast period 2020-2025.This is owing to the high preferability and availability of non-opioids drugs. Nonopioids are further segmented into   Nonsteroidal Anti-Inflammatory Drug,   Methyl Salicylate,   Capsaicin, and Lidocaine. Lidocaine is a local anesthetic that works by causing temporary numbness or loss of feeling in the skin and mucous membranes. Topical non-steroidal anti-inflammatory drugs provide good levels of pain relief in acute conditions such as sprains, strains, and overuse injuries, probably similar to that provided by oral nonsteroidal anti-inflammatory drugs. The tricyclic antidepressants most commonly used in the treatment of neuropathic pain are amitriptyline, imipramine, nortriptyline, and desipramine, as they all are potent norepinephrine reuptake inhibitors. Capsaicin topical is used for temporary relief of muscle or joint pain caused by strains, sprains, arthritis, bruising, or backaches. Capsaicin topical is also used to treat nerve pain (neuralgia) in people who have had herpes zoster or shingles. Cannabinoid receptors and endocannabinoids are present in pain circuits from the peripheral sensory nerve endings up to the brain. Cannabinoid receptor agonists modulate nociceptive thresholds by regulating neuronal activity, but they also relieve pain by acting on non-nervous tissues. The Non-Opioids is set to be the highest growing segment and is estimated to register highest CAGR during the forecast period 2020-2025.

Distribution Channel – Segment Analysis

E-Commerce segment held the largest share in the Topical Pain Relief in 2019 owing to the significant increase in digital literacy among the global population. Large population and surge in awareness about topical pain relievers among patients, rise in prevalence of diseases associated with chronic pain among the population, high awareness about the side effects caused by systemic administration of drugs and increase in the number of people suffering from migraine and schizophrenia are boosting the growth of the topical pain relief market. E-Commerce is set to be the highest growing segment and is estimated to register the highest CAGR during the forecast period 2020-2025.

Geography – Segment Analysis

North America dominated the topical pain relief market in 2019 with a share of more than 37.6% followed by the Asia Pacific. This is owing to the high population base, increase in disposable income, and improvement in patient awareness about topical pain relief products. High awareness about the side effects caused by systemic administration of drugs and an increase in the number of people suffering from migraine & schizophrenia along with the awareness and improvement in access of healthcare medication & education is set to increase the growth of the topical pain relief market in the North America region.However, Asia-Pacific is estimated to grow at a higher CAGR during the forecast period 2020-2025 owing to the rise in prevalence of chronic diseases including cancer, arthritis, and diabetes among others coupled with the increase in investments by various multinational companies. An increase in the old age group population and unhealthy food habits with the rise in awareness among patients about the adverse effects of particular drugs and associated pathways, increase in the number of patients undergoing prolonged treatment for diseases such as skin cancer is set to increase the growth of the topical pain relief market in the Asia Pacific region.

Drivers – Topical Pain Relief Market

Increase in prevalence of arthritis and other bone-related conditions

An increase in the prevalence of arthritis and other bone-related conditions is increasing the growth of the topical pain relief market owing to the development of an online platform for the topical therapeutics and high potential in untapped markets in the emerging economies.  The rise in prevalence of chronic diseases including cancer, arthritis, diabetes, growing demand in sports and athletic player, growing awareness of online pharmacy and others along with an increase in investments by various multinational companies and high demand for topical pain relievers among athletes and lesser side effects as compared to conventional oral medicines. Thus, increasing the growth of the topical pain relief market during the forecast period 2020-2025.

Increase in geriatric population and the increase in the adoption of topical pain relief by sports players

Increase in geriatric population and the increase in the adoption of topical pain relief by sports players are increasing the growth of the topical pain relief market owing to the rise in adoption of topical pain relief products as they cause lesser side effects as compared to oral pain relief, upsurge in geriatric population across the world, increase in disposable income, and improvement in patient awareness about topical pain relief products and increase in demand for topical pain relief by sports players. Thus, increasing the growth of the topical pain relief market during the forecast period 2020-2025.

Challenges – Topical Pain Relief Market

Topical pain relief medications can cause irritate skin and they have a strong odor or unpleasant smell  

Some of the factors which can impede the growth of the topical pain relief market are it causes irritated skin and they have a strong odor or unpleasant smell.

Topical Pain Relief Industry Outlook

Product launches, mergers and acquisitions, joint ventures and R&D activities are key strategies adopted by players in the topical pain relief market. In 2019, Topical Pain Relief Market share is consolidated by the top ten players present in the market. Topical Pain Relief, top 10 companies are Advacare Pharma, Glaxosmithkline Plc, Johnson Johnson, Nestl S A, Pfizer Inc., Reckitt Benckiser Group Plc, Sanofi, Sun Pharmaceutical Industry Ltd and Topical Biomedics Inc among others.
Buy Now

Acquisitions/Product Launches

  • In January 2019, Glaxosmithkline Plc acquired Tesaro.
  • In January 2020, Novartis Ag acquired The Medicines Company.

For more Lifesciences and Healthcare related reports, please click here

Advertisement

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: